A prospective, randomized controlled trial of neuromuscular electrical stimulation in patients with interstitial lung disease

A prospective, randomized controlled trial of neuromuscular electrical stimulation in patients with interstitial lung disease - Neuromuscular electrical stimulation in ILD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000040414

Enrollment

Registered

2020-05-15

Start date

2020-06-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

interstitial lung disease (ILD)

Interventions

intervention group: transcutaneous NMES of the bilateral quadriceps (five times a week, 30 minutes each session, for 12 continuous weeks) control group: usual care

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. patients with moderate to severe ILD (MRC grade 3, 4, 5) 2. clinically stable for at least 4 weeks

Exclusion criteria

Exclusion criteria: 1. severe orthopedic or neurological disorders 2. unstable cardiac disease 3. weak skin 4. malignancy 5. pregnant 6. inability to understand to use EMS equipment 7. inability to complete questionnaires

Design outcomes

Primary

Measure	Time frame
Quadriceps muscle force mMRC dyspnea scale 6-min walk distance	—

Countries

Japan

Contacts

Public ContactMasatoshi Hanada

Nagasaki University Hospital Department of Rehabilitation Medicine

mstshnd@nagasaki-u.ac.jp095-819-7258

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026